AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2021
Jun 21, 2021
34519_dirs_2021-06-21_c80cc1d7-180e-42ce-9e20-a86888f25bab.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2021-06-17
Reporting Person: Wainman Paul R (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-17 | Incentive Stock Options (Right to buy) | $10.04 | A | 10000 | Acquired | 2026-06-17 | Common Stock (10000) | Direct |
More from IMMUCELL CORP /DE/
Report Publication Announcement
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23